Cargando…
EGFR 19和21外显子突变肺癌患者的临床特征比较和预后分析
BACKGROUND AND OBJECTIVE: Studies on the epidermal growth factor receptor (EGFR) signaling pathways and the therapeutic effects of EGFR-tyrosine kinase inhibitors (EGFR-TKIs) have recently proven that targeted therapy has a major role in the treatment of lung cancer. However, the therapeutic effects...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000356/ https://www.ncbi.nlm.nih.gov/pubmed/25404271 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.11.06 |